News | August 12, 2022
Aurobindo Pharma posts consolidated Q1FY23 PAT of Rs. 520.54 Cr
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
The company has responded to the warning letter and carried out the committed corrections.
Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
Subscribe To Our Newsletter & Stay Updated
